Free Newsletter
Kemwell to double European capacity
India-based contract manufacturer Kemwell is nearly doubling its space at a facility in Uppsala, Sweden. Construction is on a fast track: The company says production in the new facility will begin this year.
The building is a 16,000-square-meter former Pfizer plant, from which Kemwell launched its European business four years ago. The CMO is boosting its operations space to 31,000 square meters to keep pace with growth.
It will use the additional space to increase production of the tablets, suppositories and capsules that are its mainstays, as well as readying the manufacturer to expand into other product types. New formulations also are in the plans, as is expansion of contractor's analytical and method development service offerings and stability studies.
- see this article
Related Articles:
Aurobindo boosts CMO wave in Asia
Biopharma contract manufacturing to sizzle
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: